TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET ANALYSIS BY TYPE, APPLICATION, REGIONS AND COMPANIES FORECAST
2024-11-27 | Pages: 200+ | Report ID: MD-R-2024-11-27-181695 | Reports
Historical data: 2018 - 2023
Forecast period: 2024 - 2031
Quantitative units: Revenue in USD million and CAGR from 2024 to 2031
Report coverage: Revenue forecast, company ranking, competitive landscape, growth factors, and trends
Transcatheter Embolization and Occlusion Devices Market
1.1 SCOPE OF THE REPORT
1.2 MARKET SEGMENT ANALYSIS
1.3 REGULATORY SCENARIO BY REGION/COUNTRY
1.4 MARKET INVESTMENT SCENARIO STRATEGIC
1.5 MARKET ANALYSIS BY TYPE (USD MILLION)
1.6 MARKET ANALYSIS BY APPLICATION (USD MILLION)
2.1 DRIVER, RESTRAINT, CHALLENGE AND OPPORTUNITIES ANALYSIS
2.1.1 MARKET DRIVER ANALYSIS
2.1.2 MARKET RESTRAINT ANALYSIS
2.1.3 MARKET OPPORTUNITY
2.1.4 MARKET CHALLENGES
3.1 INDUSTRY TRENDS
3.1.1 SWOT ANALYSIS
3.1.2 PESTEL ANALYSIS
3.1.3 PORTER’S FIVE FORCES ANALYSIS
3.2 POTENTIAL MARKET AND GROWTH POTENTIAL ANALYSIS
4.1 COVID-19 ANALYSIS
5.1 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET, SALES AREA, TYPE
5.2 MERGERS & ACQUISITIONS, PARTNERSHIPS, PRODUCT LAUNCH, AND COLLABORATION IN GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET
7.1 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE (2018-2031) (USD MILLION)
8.1 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
8.2 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
9.1 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
9.2 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
10.1 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY REGION (2018-2023) (USD MILLION)
10.2 GLOBAL TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY REGION (2024-2031) (USD MILLION)
11.1 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
11.2 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
11.3 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
11.4 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
11.5 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
11.6 NORTH AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
12.1 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
12.2 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
12.3 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
12.4 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
12.5 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
12.6 EUROPE TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
13.1 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
13.2 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
13.3 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
13.4 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
13.5 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
13.6 ASIA PACIFIC TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
14.1 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)/p>
14.2 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
14.3 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
14.4 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
14.5 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
14.6 LATIN AMERICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031) (USD MILLION)
15.1 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2018-2023) (USD MILLION)
15.2 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY COUNTRY (2024-2031) (USD MILLION)
15.3 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2018-2023) (USD MILLION)
15.4 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY TYPE (2024-2031) (USD MILLION)
15.5 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2018-2023) (USD MILLION)
15.6 MIDDLE EAST & AFRICA TRANSCATHETER EMBOLIZATION AND OCCLUSION DEVICES MARKET SIZE AND SHARE BY APPLICATION (2024-2031)< (USD MILLION)/p>
16.1 Abbott Laboratories.
16.1.1 COMPANY DETAILS
16.1.2 FINANCIALS (USD MILLION)
16.1.3 PRODUCT SUMMARY
16.1.4 RECENT DEVELOPMENTS
16.2 Boston Scientific Corporation
16.3 BTG plc
16.4 Cook Medical
16.5 Edwards Lifesciences Corporation
16.6 Johnson & Johnson Services
16.7 Inc.
16.8 Medtronic plc
16.9 Merit Medical Systems
16.10 Penumbra
16.11 Inc.
16.12 Pfizer
16.13 Inc.
16.14 Sirtex Medical Limited
16.15 Stryker Corporation
16.16 Terumo Corporation
16.17 Cardinal Health and DePuy Synthes.
18.1 METHODOLOGY
18.2 RESEARCH DATA SOURCE
18.2.1 SECONDARY DATA
18.2.2 KEY DATA FROM SECONDARY
18.2.3 PRIMARY DATA
18.2.4 KEY DATA FROM PRIMARY
18.2.5 INDUSTRY INSIGHT FROM PROFESSIONAL LEADERS
18.2.6 MARKET ESTIMATION
18.2.7 MARKET ESTIMATION: TOP-DOWN AND BOTTOM-UP APPROACH
18.2.8 LEGAL DISCLAIMER
Market Segments
Types Covered:• Coil
• Coiling-assist Devices
• Non Coil
• Accessories
• PV Embolization Coil
• PV Plugs
• Other Embolization and Occlusion Devices
Applications Covered:
• Peripheral Vascular Disease
• Neurology
• Oncology
• Urology
• Commercial (Cold Storage/Building)
• Environmental Monitoring
• Chemical
• Automobile
• Civil Household  
End Users Covered:
• Ambulatory Surgical Centers
• Clinics
• Hospitals
Companies
Abbott Laboratories.
Boston Scientific Corporation
BTG plc
Cook Medical
Edwards Lifesciences Corporation
Johnson & Johnson Services
Inc.
Medtronic plc
Merit Medical Systems
Penumbra
Inc.
Pfizer
Inc.
Sirtex Medical Limited
Stryker Corporation
Terumo Corporation
Cardinal Health and DePuy Synthes.
BROWSE INDUSTRY
- PROACTIVE
- QUALITY & RELIABILITY
- GLOBAL OUTREACH
- COMPETITIVE PRICING
WHY CHOOSE US
We manage our resources 24/7 to identify issues and address them before they become problems.
We are committed to providing reliable and highly accurate data with an excellent quality control system.
6 Major regions and 40+ countries level analysis accomplished.
Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery.